← FDA Drug Approvals (Drugs@FDA)

MACITENTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SEASONS BIOTECH · Approved 2025-12-03

Drug application

FDA Application #
ANDA211026
Application type
Abbreviated New Drug Application (Generic)
Brand name
MACITENTAN
Generic name
MACITENTAN
Active ingredients
MACITENTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
SEASONS BIOTECH
Manufacturer
Novugen Pharma (USA) LLC
First approval
2025-12-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown